93 related articles for article (PubMed ID: 8581343)
1. Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):17-24. PubMed ID: 8581343
[TBL] [Abstract][Full Text] [Related]
2. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liver.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):259-68. PubMed ID: 8680795
[TBL] [Abstract][Full Text] [Related]
4. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
Factor VM; Jensen MR; Thorgeirsson SS
Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
[TBL] [Abstract][Full Text] [Related]
6. Assessment of in vitro growth potential of hepatocytes expressing hepatocyte growth factor in an autocrine fashion.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):151-6. PubMed ID: 7994559
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.
Shiota G; Wang TC; Nakamura T; Schmidt EV
Hepatology; 1994 Apr; 19(4):962-72. PubMed ID: 8138271
[TBL] [Abstract][Full Text] [Related]
10. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
Kao CY; Factor VM; Thorgeirsson SS
Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.
Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K
Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor regulates transforming growth factor alpha in HepG2 hepatic cells.
Shiota G; Nakamura T; Schmidt EV
Biochem Biophys Res Commun; 1994 Apr; 200(2):1099-104. PubMed ID: 8179588
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):33-9. PubMed ID: 8824929
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):271-8. PubMed ID: 7827802
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF; Thorgeirsson SS
Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
[TBL] [Abstract][Full Text] [Related]
20. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC
Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
